John E. (Jack) Bailey Jr., President and CEO at G1 Therapeutics, Inc. (GTHX), sold 74,516 shares at $4.79 ($357K) on 2024-05-13, disclosed to the SEC on 2024-05-15.
Open-market sale of $357k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.79 | 37,258 | $178K | 50.0% |
| 2 | $4.79 | 37,258 | $178K | 50.0% |
| Total | $4.79 avg | 74,516 | $357K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-02 | $216K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $7K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $406K | — | Filing → |